What is it about?
This study looks at how clinical pharmacists can help manage a condition called treatment-resistant hypertension (TRH), where blood pressure remains high even with medication. In Jordan, the study found that TRH affects about 12.6% of the population. By working alongside doctors, clinical pharmacists can improve blood pressure control, medication adherence, and overall patient satisfaction. The study shows that when pharmacists provide support, patients are more likely to follow their prescribed treatments and make necessary lifestyle changes, which ultimately improves their health and quality of life.
Featured Image
Photo by Mockup Graphics on Unsplash
Why is it important?
This study is important because it shows how valuable clinical pharmacists are in managing difficult health conditions like TRH. The findings suggest that when clinical pharmacists are part of a healthcare team, patients see better results. It also highlights how integrating pharmacists into hypertension care can help doctors manage high blood pressure more effectively, reduce risks like heart disease, and improve patient well-being. This could be a model for other countries to adopt for better hypertension management.
Perspectives
Working on this study was eye-opening because it revealed the critical role that clinical pharmacists can play in improving patient care. I’ve always believed that healthcare should be a team effort, and this study further confirmed that when pharmacists collaborate with doctors, patients get better results. I’m excited to see how this research could change how we manage TRH not only in Jordan but also in other countries. The approach could potentially save lives and improve healthcare quality worldwide, and I hope it inspires healthcare systems to adopt team-based models of care. As a biomedical ethicist, this study raises key ethical issues, particularly around patient autonomy and equity. The involvement of clinical pharmacists supports patient empowerment, helping individuals make informed decisions about their care. However, ensuring equitable access to such services is crucial, especially in settings with limited resources. Additionally, the integration of clinical pharmacists into healthcare teams prompts reflection on the broader implications of team-based care and the potential structural barriers to its widespread adoption.
Dr. Hisham E. Hasan
Jordan University of Science and Technology
Read the Original
This page is a summary of: The role of clinical pharmacist in the management of resistant hypertension, Irish Journal of Medical Science (1971 -), January 2025, Springer Science + Business Media,
DOI: 10.1007/s11845-024-03863-7.
You can read the full text:
Contributors
The following have contributed to this page
